A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001)

NCT01688791 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: Vintafolide
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

Endocyte